Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Restrictions to the Use of Short Acting Beta Agonists (SABAs) in Obstetric Indications
Notice type:
3rd Party Publications
Date:
09/12/2013
Product name or type:
Restrictions to the Use of Short Acting Beta Agonists (SABAs) in Obstetric Indications
Reference:
MIMS Publication - December 2013
Background Information Or Related Documents:
Restrictions to the Use of Short Acting Beta Agonists (SABAs) in Obstetric Indications Document
Further Information:
Restrictions to the Use of Short Acting Beta Agonists (SABAs) in Obstetric Indications
« Back
Date Printed: 06/05/2024